Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The Company also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.
Ticker SymbolAKAN
Company nameAkanda Corp
IPO dateMar 15, 2022
CEOMs. Katharyn (Katie) Field
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 15
Address1A, 1B Learoyd Road
CityNEW ROMNEY
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited Kingdom
Postal codeTN28 8XU
Phone442034889514
Websitehttps://akandacorp.com/
Ticker SymbolAKAN
IPO dateMar 15, 2022
CEOMs. Katharyn (Katie) Field
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data